MagnetisMM-20

Phase 1B Study Evaluating Elranatamab in Combination with Carfilzomib/Dexamethasone or in Combination with PF-07901801 (maplirpacept) in Relapsed/Refractory Multiple Myeloma

Arms / Cohorts

Experimental:Part 2A: Elranatamab and Maplirpacept

Accepting patients

Experimental: Dose Escalation:Part 1: Elranatamab, Carfilzomib and Dexamethasone

Accepting patients

Experimental, Dose Randomization:Part 2B: Elranatamab and Maplirpacept

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.